ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Spherix Inc

Spherix Inc (SPEX)

1.63
0.00
(0.00%)
Closed January 09 3:00PM
0.00
0.00
(0.00%)

Professional-Grade Tools, for Individual Investors.

Key stats and details

Current Price
1.63
Bid
1.56
Ask
1.58
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Market Cap
Previous Close
1.63
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
-
Shares Outstanding
5,345,000
Dividend Yield
-
PE Ratio
-0.38
Earnings Per Share (EPS)
-4.28
Revenue
2.04M
Net Profit
-22.88M

About Spherix Inc

Spherix Inc is a United States-based biotechnology company. The company is engaged in the development of small-molecule anti-cancer therapeutics. The company's drug portfolio includes therapies for pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL). Spherix Inc is a United States-based biotechnology company. The company is engaged in the development of small-molecule anti-cancer therapeutics. The company's drug portfolio includes therapies for pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL).

Sector
Security Brokers & Dealers
Industry
Security Brokers & Dealers
Headquarters
Wilmington, Delaware, USA
Founded
-

SPEX Latest News

AIkido Pharma Appoints Dr. Scott T. Tagawa, M.D. to Scientific Advisory Board

AIkido Pharma Appoints Dr. Scott T. Tagawa, M.D. to Scientific Advisory Board PR Newswire NEW YORK, Feb. 3, 2021 NEW YORK, Feb. 3, 2021 /PRNewswire/ -- AIkido Pharma Inc. (Nasdaq: AIKI) ("AIkido...

Aikido Pharma Secures Early Interest in Next Generation Radiotherapy

Aikido Pharma Secures Early Interest in Next Generation Radiotherapy Currently in Human Phase 2 Trials for Treatment of Prostate Cancer PR Newswire NEW YORK, Feb. 1, 2021 NEW YORK, Feb. 1, 2021...

Spherix Completes Enrollment in NEET, a Phase 3 Clinical Trial Evaluating an Oral Drug for Type 2 Diabetes

Company Signs Long-term Supply Agreement for Pharmaceutical D-tagatose BETHESDA, Md., Jan. 12 /PRNewswire-FirstCall/ -- Spherix Inc. (Nasdaq SPEX), an innovator in biotechnology for diabetes...

Spherix to Present at Annual OneMedPlace Finance Forum and at EBD Biotech Showcase in San Francisco

BETHESDA, Md., Jan. 11 /PRNewswire-FirstCall/ -- Spherix Inc. (NASDAQ: SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services...

Spherix Announces the Closing of $6.3 Million Registered Direct Offering

BETHESDA, Md., Nov. 19 /PRNewswire-FirstCall/ -- Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting...

Spherix Announces the Closing of $6.3 Million Registered Direct Offering

BETHESDA, Md., Nov. 19 /PRNewswire-FirstCall/ -- Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting...

Spherix Announces Results of Annual Shareholders Meeting

BETHESDA, Md., Nov. 19 /PRNewswire-FirstCall/ -- Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting...

Spherix Incorporated Appoints Dr. Ram Nimmagudda As Director of New Business Development

BETHESDA, Md., Sept 10 /PRNewswire-FirstCall/ -- Spherix Incorporated (NASDAQ:SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting...

Spherix Incorporated to Present at the Rodman & Renshaw 11th Annual Healthcare Conference

BETHESDA, Md., Sept. 3 /PRNewswire-FirstCall/ -- Spherix Inc. (NASDAQ: SPEX), an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services...

Spherix Announces Positive Phase 2 Study Results

Preliminary Data Demonstrates Reduction of HbA1c Levels With Doses an Order of Magnitude Lower than the Dose Used in the Current Phase 3 Trial. BETHESDA, Md., June 24 /PRNewswire-FirstCall/...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

SPEX - Frequently Asked Questions (FAQ)

What is the current Spherix share price?
The current share price of Spherix is US$ 1.63
How many Spherix shares are in issue?
Spherix has 5,345,000 shares in issue
What is the market cap of Spherix?
The market capitalisation of Spherix is USD 8.71M
What is the 1 year trading range for Spherix share price?
Spherix has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of Spherix?
The price to earnings ratio of Spherix is -0.38
What is the cash to sales ratio of Spherix?
The cash to sales ratio of Spherix is 4.27
What is the reporting currency for Spherix?
Spherix reports financial results in USD
What is the latest annual turnover for Spherix?
The latest annual turnover of Spherix is USD 2.04M
What is the latest annual profit for Spherix?
The latest annual profit of Spherix is USD -22.88M
What is the registered address of Spherix?
The registered address for Spherix is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the Spherix website address?
The website address for Spherix is www.dominariholdings.com
Which industry sector does Spherix operate in?
Spherix operates in the SECURITY BROKERS & DEALERS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
AALAmerican Airlines Group Inc
US$ 17.60
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 71.1445
(0.00%)
0
AADIAadi Bioscience Inc
US$ 3.60
(0.00%)
0
AACGATA Creativity Global
US$ 0.9791
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 17.60
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 71.1445
(0.00%)
0
AADIAadi Bioscience Inc
US$ 3.60
(0.00%)
0
AACGATA Creativity Global
US$ 0.9791
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 17.60
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 71.1445
(0.00%)
0
AADIAadi Bioscience Inc
US$ 3.60
(0.00%)
0
AACGATA Creativity Global
US$ 0.9791
(0.00%)
0

Discussion

View Full Feed
familyof5 familyof5 2 minutes ago
You got to stop talking like this! Your making some people nervous! Like that ihub bashing PYSOP flash mob that has no vested interest here but can’t seem to stay away lol
HMBL
StayHumble StayHumble 3 minutes ago
💹$HYCM💹on the SILVER screen💹the GoldenGlobe💹💹 wow
HYCM
KevGee59 KevGee59 3 minutes ago
that will never be said about trump
Actually...it's already been said about Trump.

It was said over 72 million times November 5th. ;)
NWBO
cjstocksup cjstocksup 3 minutes ago
I live here. State Farm told me 2 years ago if CA would not let them increase rates they would be forced to leave. They were forced to leave the state as far as homeowners' insurance last summer. I know many who have been trying to find new insurance for the last year. If you own your home, you do n
benz280e benz280e 3 minutes ago
The hostages in Iran were happy to see Jimmy go, worthless 
GDVM
Acme Investments Acme Investments 4 minutes ago
I've been retired for 15 years and it's very important to find another passion!! That part I understand!! Not like you can go play a pickup game!! LOL 😂
RDAR
StayHumble StayHumble 4 minutes ago
$AMC Silver investments Golden💹 ShortFilmXplosion Coming💹 wow!

"......shows about to start..."
https://cdn.vox-cdn.com/uploads/chorus_asset/file/8687957/tenor.gif
AMC
F14SVF24 F14SVF24 4 minutes ago
It is so fortunate for us actual shareholders that we have girls like you to help us navigate these turbulent HMBL waters. Thanks.
HMBL
Citrati Citrati 5 minutes ago
Whatever dude.

Here is what the internet concludes

"Reasons Insiders Sell Stock"

There are multiple reasons why insiders may sell company stock, and it’s important to understand the reasons for these sales before letting them impact your own decisions. Ac
JOBY
BottomBounce BottomBounce 5 minutes ago
C3.ai, Inc. $AI Total Debt (mrq) $5.12M Book Value Per Share (mrq) $7.06
AI
BottomBounce BottomBounce 5 minutes ago
C3.ai, Inc. $AI Total Debt (mrq) $5.12M Book Value Per Share (mrq) $7.06
AI
capgain capgain 6 minutes ago
He's very underrated.

He's a master Tele player IMO.
crescentmotor crescentmotor 6 minutes ago
Always knew the markets were corrupt and rigged.

Realization of that truth early on no doubt was a large factor in your being able to successfully stay in the game as an options player. The leverage can be wonderful but statistics show that most all players get hosed. I love using
AVXL
La Flaca La Flaca 6 minutes ago
what information are you talking about?
AVXL
Ayock Ayock 6 minutes ago
I'll drop by occasionally to see your Fascist view of current events...

djt is a disgusting human and embarrassment to the Office of President of the United States. He will benefit for the next one and a half to two years from the current powerhouse Biden/Harris middle out economy. He
B60611 B60611 7 minutes ago
Wow, I very much respect your on-topic posting, but you sound 100% like frrrol, and equally ridiculous.
AVXL
Acme Investments Acme Investments 8 minutes ago
👇 They got the custodianship right!! Which you have yet to admit you were WRONG on!! Zero accomplishment's in life will leave you wondering!! You try until you get it right!! Trial and error!! Basic man training!!
BCAP
ProfitChaser ProfitChaser 8 minutes ago
They actually only said the 1st part. LOL. The rest was added by a trader..

KRTLBIOTECH OTC:KRTL
@KRTLBiotech
·
21h
“Attention $KRTL shareholders: Congratulations on today’s press release announcement! To clarify, our 55% majority stake was acquired by prov
KRTL
flipper44 flipper44 8 minutes ago
I don’t think that precedent of sorts slowed the case by much at all. It really kind of clarified matters, imo. It’s just been a long time for the outstanding MTD recommendation.
NWBO
Myth Myth 8 minutes ago
I remember listening to GE back in his SNL days and thinking, who is this guy ??

the live audience got to hear him play while we watched a commercial, all we got was a little taste at the end..

effed up I say !
raiderz raiderz 9 minutes ago
Is the new website almost complete?
🤣

We need a business model, and an audit, and a leadership team, and a reverse split.

Good luck to us.
HIRU
Jackxkr Jackxkr 9 minutes ago
Settlement amounts have nothing to do with the judge nor does punitive damages come into play. Settlements are what the two partys come to agreement to in order not to get to a decision and possible punitive damages, back to your emojis.
NWBO
mwab52 mwab52 9 minutes ago
Sweet!!!!!!!!!!!!! 🤑😎 !!!!!!!!!!!!!!! G0 (RNVA & Team)
RNVA
janice shell janice shell 9 minutes ago
The article is written like they were going to do a 1:2 and then changed their mind to 1:100. But that is not that case they merely provided the range the Board can decide within of 1:2 up to 1:100.

And that is exactly what they did last time.
MULN
Just the facts maam Just the facts maam 10 minutes ago
Another reason begging for an approved female testosterone drug

https://bmcmusculoskeletdisord.biomedcentral.com/articles/10.1186/s12891-024-08272-6 Correlation between low testosterone levels and the risk of osteoarthritis: a cross-sectional analysis of NHANES data (2011–2016)
ANIP

Your Recent History

Delayed Upgrade Clock